Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Qing Guan

Ocean University of China

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · JOURNAL ARTICLE

Engineered bacteria as exogenous organelle mimics restore PTEN and p53 tumor suppressor functions for cancer therapy

Nature Communications

This is a proof-of-concept study in murine melanoma using a novel engineered bacterial platform with surrogate endpoints; efficacy and safety in humans remain untested.

PreliminaryYaxin Wang Maoqin Wang R. Liu

Reported

Tumor inhibition94.9%

Survival outcomeall treated mice

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support